Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice

Signal Transduct Target Ther. 2021 Dec 13;6(1):419. doi: 10.1038/s41392-021-00843-6.

Authors

Wenjuan Li^#¹, Xingxing Li^#¹, Danhua Zhao^#¹, Jingjing Liu¹, Ling Wang¹, Miao Li¹, Xinyu Liu¹, Jia Li¹, Xiaohong Wu², Yuhua Li³

Affiliations

¹ Department of Arboviral Vaccine, National Institutes for Food and Drug Control, 102629, Beijing, China.
² Department of Arboviral Vaccine, National Institutes for Food and Drug Control, 102629, Beijing, China. wuxiaohong@nifdc.org.cn.
³ Department of Arboviral Vaccine, National Institutes for Food and Drug Control, 102629, Beijing, China. liyuhua@nifdc.org.cn.

^# Contributed equally.

No abstract available

Publication types

Letter
Comment

MeSH terms

Animals
COVID-19 Vaccines*
COVID-19*
Humans
Immunity
Mice
RNA, Messenger / genetics
SARS-CoV-2

Substances

COVID-19 Vaccines
RNA, Messenger